Reach Us +44-1904-929220
Investigation Of Annexin A5 As A Biomarker For Alzheimer?s Disease And Dementia With Lewy Bodies | 3520

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Investigation of annexin A5 as a biomarker for Alzheimer?s disease and Dementia with Lewy bodies

3rd International Conference on Biomarkers & Clinical Research

Hitoshi Sohma

Keynote: J Mol Biomark Diagn

DOI: 10.4172/2155-9929.S1.008

Alzheimer?s disease (AD) differs from other forms of dementia in its relation to amyloid beta peptide (A☐42). Using a cell culture model we previously identified annexin A5, a Ca2+ and phospholipid binding protein, as an AD biomarker. Plasma level of annexin A5 was significantly higher in AD patients compared to that in a control group. As AD shares clinical and pathological features with Dementia with Lewy bodies (DLB), the present study was done to examine the similarity of AD and DLB using the plasma AD biomarker annexin A5.
Hitoshi Sohma completed his Ph.D. in biochemistry at Hokkaido University, Japan, focusing on Ca2+-signaling in cell-cell communications, and his postdoctoral studies at the National Institute of Mental Health, NIH. He is a professor in the Department of Educational Development, Sapporo Medical University Center for Medical Education, Sapporo, Japan. He is also involved in both pathobiochemical research and the management of medical education at the university.
Relevant Topics